1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow Mark Evers: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TVB 2640 for Resectable Colon Cancer Other Resectable Cancers; a Window Trial. TVB-2640, Placebo - Colon Cancer | Phase 1 | Terminated | Mark Evers | 23 | 2017-10-06 | 2024-10-22 |
TVB-2640 (1)
United States (1)
Mark B Evers, MD (1)
R01CA208343 (1)